D Ogston, A S Douglas. Show Affiliations »
Abstract
Mesh: See more » Aminocaproates/pharmacologyAnticoagulants/administration & dosageAnticoagulants/antagonists & inhibitorsAnticoagulants/pharmacologyAnticoagulants/therapeutic useAntifibrinolytic AgentsBlood Coagulation/drug effectsBlood Platelets/drug effectsCoumarins/administration & dosageCoumarins/antagonists & inhibitorsCoumarins/pharmacologyCyclohexanecarboxylic Acids/pharmacologyDipyridamole/pharmacologyEthylestrenol/pharmacologyFactor XIIFactor XIIIFibrin/pharmacologyFibrinogenFibrinolysin/pharmacologyFibrinolytic Agents/administration & dosageFibrinolytic Agents/pharmacologyFibrinolytic Agents/therapeutic useHeparin/administration & dosageHeparin/pharmacologyHeparin AntagonistsHumansIndenes/pharmacologyPeptide Hydrolases/adverse effectsPeptides/pharmacologyPhenformin/pharmacologyPlasminogen/pharmacologyProtamines/pharmacologyStreptokinase/pharmacologyThrombinThromboembolism/drug therapyThromboembolism/etiologyVitamin K/pharmacology
Substances: See more » AminocaproatesAnticoagulantsAntifibrinolytic AgentsCoumarinsCyclohexanecarboxylic AcidsFibrinolytic AgentsHeparin AntagonistsIndenesPeptidesProtaminesVitamin KDipyridamoleFactor XIIFibrinFibrinogenPlasminogenHeparinFactor XIIIEthylestrenolPhenforminPeptide HydrolasesStreptokinaseThrombinFibrinolysin
Year: 1971 PMID: 4256645 DOI: 10.2165/00003495-197101030-00003
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546